
Translate guidelines and evidence for integrating cognitive assessment tools, imaging, and biomarkers to the clinical diagnosis of Alzheimer’s disease at all stages.
Summarize benefits and limitations of current Alzheimer’s disease therapies based on the cholinergic hypothesis.
Outline emerging clinical trial data on potential augmentation therapies and anti-beta-amyloid agents for the treatment of early Alzheimer’s disease.
1.5 Free CEUs for Pharmacists
Expires 12/19/14